Allegra Leghissa Joins Cannabis Science and Technology’s Editorial Advisory Board
Cannabis Science and Technology is pleased to announce the addition of Allegra Leghissa, PhD, to its editorial advisory board (EAB).
Allegra Leghissa, PhD
Cannabis Science and Technology is pleased to announce the addition of Allegra Leghissa, PhD, to its editorial advisory board (EAB).
Dr. Allegra Leghissa graduated from the University of Bologna, Italy with an undergraduate degree in Chemistry in 2014 and a PhD in analytical chemistry from the University of Texas, Arlington in 2018. Under the supervision of Professor Kevin Schug, she worked on the analysis of terpenes and cannabinoids in cannabis and specifically delta-9-THC metabolites by gas chromatography–tandem mass spectrometry (GC–MS/MS). She also had some experience with the analysis of these components by liquid chromatography (LC)–MS/MS. Her experience in the field of cannabis testing was solidified through participation in relevant conferences and seminars.
Dr. Leghissa is currently an LC–MS/MS application engineer with Shimadzu France.
California Moves to Cement Emergency Rules Restricting Hemp-Derived Products
June 18th 2025Proposed regulations from the Department of Health would make permanent the emergency rules banning THC in hemp-derived food, beverage, and dietary products while restricting sales to adults 21 and older.
Ep 26: Innovations in Drying and Curing to Protect Flower Quality
May 27th 2025In this latest installment of Noid Knowledge, we are joined by Dr. Allison Justice, Founder and CEO of the Hemp Mine, and David Sandelman COO, CTO & Co-Founder of Cannatrol. Here, Allison and David discuss innovations in cannabis drying and curing, focusing on the Cannatrol technology which controls vapor pressure, preserving trichome integrity, and flower quality. Additionally, Allison shares how the Cannabis Research Center and Coalition (CRC) is transition to an open-source model to support cultivators, researchers, and home growers.
Global Survey Examines Cannabis Use over Pharmaceuticals for Endometriosis Symptom Relief
June 17th 2025A survey of nearly 900 endometriosis patients across 28 countries highlights cannabis as a preferred alternative to pharmaceuticals, despite legal, social, and medical communication barriers.
Ep 25: Cannabis Quality Differentiation Beyond Cannabinoid Content
February 28th 2025In this latest installment of Noid Knowledge we are joined by Julie Kowalski, a leading mind in analytical chemistry and cannabis testing. Julie has arranged a very compelling symposium for Pittcon entitled Cannabis Aroma: Advances and Challenges in Determining and Commercializing Cannabis Product Quality Attributes. It is taking place on Wednesday, March 5, 2025, starting at 9:30 AM in room 209. The session features top notch speakers, including several previous guests of this show, and yours truly, discussing the next generation of quality assessment in cannabis.
